Equities research analysts expect MINDBODY Inc (NASDAQ:MB) to report $65.71 million in sales for the current quarter, Zacks reports. Nine analysts have provided estimates for MINDBODY’s earnings, with the lowest sales estimate coming in at $65.27 million and the highest estimate coming in at $66.38 million. MINDBODY posted sales of $49.69 million in the same quarter last year, which suggests a positive year over year growth rate of 32.2%. The business is scheduled to report its next quarterly earnings report on Wednesday, February 20th.

On average, analysts expect that MINDBODY will report full year sales of $244.96 million for the current year, with estimates ranging from $244.49 million to $245.59 million. For the next year, analysts anticipate that the business will report sales of $296.12 million, with estimates ranging from $285.45 million to $305.60 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that follow MINDBODY.

MINDBODY (NASDAQ:MB) last posted its earnings results on Tuesday, November 6th. The technology company reported ($0.05) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.07) by $0.02. MINDBODY had a negative return on equity of 9.15% and a negative net margin of 16.91%. The firm had revenue of $63.80 million for the quarter, compared to analyst estimates of $63.99 million. During the same quarter in the prior year, the company earned $0.01 EPS. MINDBODY’s revenue was up 36.9% on a year-over-year basis.

MB has been the topic of a number of analyst reports. BidaskClub lowered MINDBODY from a “buy” rating to a “hold” rating in a research report on Thursday, November 8th. Imperial Capital reduced their price target on MINDBODY from $42.00 to $36.00 and set an “outperform” rating on the stock in a research report on Thursday, November 8th. ValuEngine lowered MINDBODY from a “buy” rating to a “hold” rating in a research report on Wednesday, November 7th. TheStreet lowered MINDBODY from a “c-” rating to a “d+” rating in a research report on Wednesday, November 7th. Finally, JPMorgan Chase & Co. lowered MINDBODY from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $48.00 to $31.00 in a research report on Wednesday, November 7th. Ten research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $33.70.

In other MINDBODY news, CEO Richard Lee Stollmeyer sold 17,739 shares of MINDBODY stock in a transaction that occurred on Thursday, November 1st. The stock was sold at an average price of $32.98, for a total value of $585,032.22. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Michael Joseph Mansbach sold 3,705 shares of MINDBODY stock in a transaction that occurred on Tuesday, August 21st. The shares were sold at an average price of $35.25, for a total value of $130,601.25. The disclosure for this sale can be found here. Insiders sold a total of 127,809 shares of company stock worth $4,430,896 over the last quarter. Company insiders own 6.02% of the company’s stock.

Several institutional investors have recently bought and sold shares of the stock. FMR LLC boosted its stake in shares of MINDBODY by 1.2% in the second quarter. FMR LLC now owns 6,565,617 shares of the technology company’s stock valued at $253,433,000 after buying an additional 75,307 shares in the last quarter. Capital World Investors boosted its stake in shares of MINDBODY by 2.3% in the third quarter. Capital World Investors now owns 3,650,000 shares of the technology company’s stock valued at $148,373,000 after buying an additional 82,000 shares in the last quarter. BlackRock Inc. boosted its stake in shares of MINDBODY by 2.8% in the third quarter. BlackRock Inc. now owns 2,717,223 shares of the technology company’s stock valued at $110,454,000 after buying an additional 74,838 shares in the last quarter. Institutional Venture Management XIII LLC boosted its stake in shares of MINDBODY by 0.5% in the second quarter. Institutional Venture Management XIII LLC now owns 2,655,365 shares of the technology company’s stock valued at $102,497,000 after buying an additional 13,333 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of MINDBODY by 4.8% in the third quarter. Victory Capital Management Inc. now owns 1,493,985 shares of the technology company’s stock valued at $60,731,000 after buying an additional 68,315 shares in the last quarter.

MB traded down $0.52 during mid-day trading on Wednesday, hitting $25.48. 788,500 shares of the stock were exchanged, compared to its average volume of 634,008. MINDBODY has a 1-year low of $24.75 and a 1-year high of $45.50. The company has a current ratio of 9.45, a quick ratio of 9.45 and a debt-to-equity ratio of 0.89. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of -84.93 and a beta of 0.35.

About MINDBODY

MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.

Featured Story: What kind of dividend yield to CEF’s pay?

Get a free copy of the Zacks research report on MINDBODY (MB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.